Lv11
22 积分 2023-04-18 加入
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
48分钟前
待确认
Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy
59分钟前
已完结
Early Treatment Initiation Optimizes Virologic and Liver Outcomes in Pediatric Patients With Chronic Hepatitis B Aged 0 to 18 Years
3个月前
已关闭
Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B
3个月前
已完结
Peginterferon α-2b Enhances HBsAg Loss in NA-Suppressed Low-HBsAg Chronic Hepatitis B Patients: Everest Study in China
4个月前
已完结
Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial
7个月前
已完结
Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy
7个月前
已完结
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry
7个月前
已完结
Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak
9个月前
已完结
Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon‐based therapy
9个月前
已完结
皖公网安备34019202002308
